Market Place
Sourcing Support
Roche culls ph. 3 Spark gene therapy in hemophilia
18 Dec 2024 //
FIERCE BIOTECH
AbbVie buys Roche spinout Nimble Therapeutics for $200M
14 Dec 2024 //
PRESS RELEASE
Roche Receives CE Mark for Updated Molecular 6800/8800 Systems
12 Dec 2024 //
GLOBENEWSWIRE
Roche’s Vabysmo PFS Approved for Three Retinal Conditions in EU
12 Dec 2024 //
GLOBENEWSWIRE
A look at how Roche`s $1.5B Poseida buyout came together
10 Dec 2024 //
FIERCE BIOTECH
Roche`s subQ Lunsumio matches IV version in lymphoma
10 Dec 2024 //
FIERCE PHARMA
ASH: Lilly defends survival data blemish in novel BTK trial win
09 Dec 2024 //
FIERCE PHARMA
Roche’s Polivy Confirmed as Standard for Lymphoma Treatment
08 Dec 2024 //
GLOBENEWSWIRE
Roche Partners With COUR in Autoimmune Deal Worth $900M
04 Dec 2024 //
BIOSPACE
Roche records setback in phase III study of two lung cancer drugs
26 Nov 2024 //
REUTERS
Roche agreement to acquire Poseida Therapeutics
26 Nov 2024 //
GLOBENEWSWIRE
Roche Receives FDA Approval for Diagnostic in Biliary Tract Cancer
25 Nov 2024 //
PR NEWSWIRE
Roche files patent suit to fend off potential Evrysdi generics
20 Nov 2024 //
FIERCE PHARMA
Revelation Pharma Congratulates David on NH State Senate Election
19 Nov 2024 //
PR NEWSWIRE
Neuron23 to Use Roche’s Digital Biomarker in Parkinson’s Trial
19 Nov 2024 //
BUSINESSWIRE
Neuron23 Unveils Phase 2 Trial in Early Parkinson’s Disease
19 Nov 2024 //
BUSINESSWIRE
Roche Receives CE Mark for VENTANA FOLR1 Assay in Ovarian Cancer
18 Nov 2024 //
PR NEWSWIRE
Flare Therapeutics Enters Discovery Collaboration with Roche
14 Nov 2024 //
BUSINESSWIRE
Roche stakes over $1.8B on cancer-linked transcription factors
13 Nov 2024 //
BIOSPACE
Flare Therapeutics Partners with Roche to Target Transcription Factors
12 Nov 2024 //
PR NEWSWIRE
Genentech axes Nykode cancer vaccine deal
09 Nov 2024 //
FIERCE BIOTECH
Vaccinex Reports Immunity Benefit with Pepinemab at SITC Meeting
05 Nov 2024 //
GLOBENEWSWIRE
Roche Presents Long-Term Data Across Hematology Portfolio at ASH
05 Nov 2024 //
GLOBENEWSWIRE
Genentech to Share Long-term Data at ASH 2024 Hematology
05 Nov 2024 //
BUSINESSWIRE
PredicineCARE Featured in NEJM for Roche’s Ph 3 Breast Cancer Trial
04 Nov 2024 //
GLOBENEWSWIRE
UCB`s tau drug flunks Alzheimer`s trial days after Roche`s exit
01 Nov 2024 //
FIERCE BIOTECH
Roche collects more data on blood tests for Alzheimer’s disease
31 Oct 2024 //
FIERCE BIOTECH
Vaccinex Reports SIGNAL-AD Data for Pepinemab at CTAD
31 Oct 2024 //
GLOBENEWSWIRE
Publishes Ph 3 Results for Roche’s Itovebi in HR+ve Breast Cancer
31 Oct 2024 //
GLOBENEWSWIRE
Roche Presents Alzheimer’s Diagnostics Data at CTAD
31 Oct 2024 //
GLOBENEWSWIRE
Patient death prompts Roche to adjust Alzheimer`s trial
31 Oct 2024 //
FIERCE PHARMA
High Court reinstates Injunction stopping sale of Zydus’ Sigrima
29 Oct 2024 //
EXPRESSPHARMA
Roche bets up to $1B to expand Dyno gene therapy delivery pact
25 Oct 2024 //
FIERCE BIOTECH
Roche`s Vabysmo will rise above Eylea biosim threat, exec says
24 Oct 2024 //
FIERCE PHARMA
CDC revamps last year`s `Wild to Mild` flu vaccine campaign
24 Oct 2024 //
FIERCE PHARMA
Roche culls cough candidate, pivots KRAS after revaluing pipeline
24 Oct 2024 //
FIERCE BIOTECH
Roche CEO critiques Novo`s proposed Catalent buyout
23 Oct 2024 //
FIERCE PHARMA
Roche Reports 9% Sales Growth In Q3 2024
23 Oct 2024 //
GLOBENEWSWIRE
Roche CEO Says Closing Novo-Catalent Deal Would Be Wrong Decision
23 Oct 2024 //
ENDPTS
Roche tosses out $120M tau prospect, returning rights to UCB
23 Oct 2024 //
FIERCE BIOTECH
Roche CEO says more people have mpox in Europe than has been reported
22 Oct 2024 //
REUTERS
Roche comes out against takeover of manufacturer Catalent
22 Oct 2024 //
REUTERS
Roche’s Alecensa receives NICE to treat ALK-positive lung cancer
22 Oct 2024 //
PMLIVE
Roche’s Vabysmo Improves Vision In DME Underrepresented Groups
19 Oct 2024 //
INDPHARMAPOST
Roche MAGE-A4 trial withdrawn after strategic review
19 Oct 2024 //
FIERCE BIOTECH
Roche Gets FDA Approval For Companion Diagnostic For Vyloy
18 Oct 2024 //
PR NEWSWIRE
Roche’s Vabysmo Improves Vision In Underrepresented DME Groups.
18 Oct 2024 //
GLOBENEWSWIRE
Noema ticks off phase 2a Tourette win for ex-Roche molecule
17 Oct 2024 //
FIERCE BIOTECH
Roche`s Evrysdi Shows Positive Results In Children With SMA
14 Oct 2024 //
GLOBENEWSWIRE
Roche burnishes breast cancer portfolio with FDA nod for Itovebi
11 Oct 2024 //
FIERCE PHARMA
Tempest And Roche Agreement to Amezalpat For Hepatocellular Carcinoma
10 Oct 2024 //
GLOBENEWSWIRE
Roche Gets CE Certification For Gastric Cancer Companion Test
10 Oct 2024 //
GLOBENEWSWIRE
Clearside`s CLS-AX excels in phase 2b trial, set for phase 3
10 Oct 2024 //
FIERCE PHARMA
breast cancer pill could enter $12 bln market if trials succeed
09 Oct 2024 //
REUTERS
Lonza Completes Acquisition of Biologics Site from Roche
01 Oct 2024 //
CONTRACT PHARMA
Roche targets more than $3 billion in annual obesity sales
01 Oct 2024 //
REUTERS
Roche rolls out 12-virus diagnostic test in Europe
24 Sep 2024 //
FIERCE BIOTECH
Xofluza Reduces Influenza Transmission In Phase III Study
19 Sep 2024 //
GLOBENEWSWIRE
Boehringer`s Lung Fibrosis Trial Meets Primary Endpoint
17 Sep 2024 //
FIERCE BIOTECH
Roche`s Tecentriq Hybreza wins first FDA approval for a subcutaneous PD-L1 drug
14 Sep 2024 //
FIERCE PHARMA
